Research Studies: Bipolar Disorder

DBSA does not endorse nor recommend any particular research study. Patients should discuss all options with their health care providers and family members before beginning any study.

Many people think that participating in a research study means they will get better treatment for their illness. While this may be true, it's important to remember that a research study is conducted for research purposes—it does not ensure better or safer treatment.

Taking part in a study does not guarantee individual benefits to the participant in the form of newer or safer treatment. The contribution made participating in a research study is to science first and to the patient second.

DBSA, its advisors, and consultants do not endorse or recommend the use of any specific treatment or medication. For advice about specific treatment or medication, patients should consult their physicians and/or mental health professionals.


The Experience of Pregnancy for Women with Bipolar Disorder (Phone Survey)

We are recruiting women who:
Are at least 18 years old
Are within 18 months postpartum of their most recent pregnancy
Have a history of bipolar disorder or manic depression

You may qualify for a research study that could help researchers at the University of North Carolina-Chapel Hill Nursing School better understand the experience of pregnancy for women with bipolar disorder. If you qualify, this research project involves a 1-2 hour telephone interview where we will ask you about your most recent pregnancy experience and a short online questionnaire about your emotions. If you would like to participate in this study, please complete this brief online screening tool: http://bpdpregnancy.com, or e-mail erinrich@email.unc.edu to complete it over the phone. Compensation for this study is a $15 gift card to Target or Wal-Mart.

Contact:
Erin Richardson
Phone: 919-943-8999
Email:erinrich@email.unc.edu

Deadline for Enrollment: 10/1/2014


The Interactions of Adults and their Family Members with a Mental Illness (Online Survey)

Do you have a living adult family member who has been diagnosed with a mental illness? Are you willing to spend approximately 15 minutes taking an online research survey? Participants who complete the survey will be entered in a lottery to receive 1 of 8 $50 e-gift cards to either Amazon.com or Walmart.com.

Researchers at the University of Pennsylvania are conducting a study regarding the types of interactions people have with their relative with a mental illness. To be eligible to participate you should be least 18 years of age and have an adult romantic partner or relative (by birth or law) who has been diagnosed with a mental illness. If you decide to participate you will be asked to answer questions regarding yourself, your relative with a mental illness, and the interactions you and your relative with a mental illness have with each other. If you are interesting in completing the online survey, please click on the link below and follow the instructions. Your participation would be greatly appreciated! If you have any questions or would like further information about this research study, please contact Travis Labrum with the School of Social Policy & Practice, University of Pennsylvania, at tlabrum@sp2.upenn.edu

Take the survey!

Contact:
Travis Labrum
Phone: 801-647-3433
Email: travis_labrum@hotmail.com

Deadline for Enrollment: 12/21/2014


Efficacy of a Brief Treatment for Chronic Nightmares and Sleep Disturbances among Trauma-Exposed Persons with Bipolar Disorder (Tulsa, Oklahoma)

This research study is investigating a 5-session cognitive-behavioral treatment for men and women diagnosed with bipolar disorder, who suffer from chronic nightmares and have experienced a traumatic event during their lifetime.

Treatment is provided free of charge and participants are compensated for post-treatment evaluations. The Institutional Review Board has approved this study to confirm it is ethical and safe.

There is no restriction from receiving other treatments. Participants will be required to be receiving treatment for their bipolar symptoms. All participants will receive the active treatment.

Contact:
Katherine Miller
Phone: 918-631-3976
Email: davis.traumalab@gmail.com

Deadline for Enrollment: July 15, 2015


Potential Use of Brain Network Activation (BNA) Analysis Using Evoked Response Potentials to Diagnose Unipolar Major Depression and Bipolar I Depression and Assess Response to Treatment (Skokie, IL)

Help researchers find the biological indicator of depression and bipolar disorder by participating in the Brain Network Activation study (i.e., EEG)! If you are currently battling depression or bipolar disorder, you may qualify to participate in the study.

This study lasts 6-8 weeks and involves a non-invasive treatment. If you aren't currently receiving medication, you will receive one that is already FDA-approved. The study consists of approximately three visits with an EEG conducted at each. Upon the end of the study, study completers may be eligible for up to 90 days of free treatment.

Contact:
Rae Watkins, PsyD
Phone: (847) 679-8000
Email: rae_watkins@rush.edu
www.elminda.com

Deadline for Enrollment: January 5, 2016


Pathophysiology and Treatment of Bipolar Disorder as assessed by In Vivo Imaging (Stony Brook, NY)

The purpose of this study is to identify changes in the brain chemistry of patients with bipolar disorder, and to measure differences in brain chemistry before and after treatment for bipolar depression. The treatments being studied are lithium and lamotrigine (Lamictal).

Contact:
Sunia Choudhury
Phone: 631-638-1544
Email: sunia.choudhury@stonybrookmedicine.edu

Deadline for enrollment: 7/10/16


Bipolar Disorder & Technology Use (Online)

At Cornell University we are looking at the use of technology by people who have bipolar disorder. This questionnaire will help us better understand your use of technology which will in turn help us design computer tools for people with bipolar disorder.

What we will ask you to do: Your participation involves answering a number of questions about your use of technology and should take about 10 minutes. 

Compensation: You will receive no direct benefit for participating in this study. If you choose, you can enter your email address at the end of the survey for the chance to win an iPad mini.

To participate please visit:
https://cornell.qualtrics.com/SE/?SID=SV_6YgPdDvUEB2HlUF

Contact:
Mark Matthews
Phone: 607-262-0754
Email: mjm672@cornell.edu

Deadline for Enrollment: 10/31/2014


MoodSwings: An Online Self-Help Program for Bipolar Disorder

We are recruiting people who:

  • Are aged between 21 and 65
  • Have a diagnosis of bipolar disorder

You are invited to participate in this research study to evaluate the MoodSwings online self-help program for bipolar disorder. We are interested in understanding how intensive the MoodSwings program needs to be to improve well-being in people with bipolar disorder, so we have 3 levels of access for participants involved in this study:

  • Group 1: Access to a moderated discussion board to communicate with other participants and discuss issues related to bipolar disorder.
  • Group 2: Access to a moderated discussion board and a series of learning modules covering a range of topics related to bipolar disorder.
  • Group 3: Access to a moderated discussion board, a series of learning modules and a number of interactive tools designed to help you monitor your moods and manage your treatment.

If you are eligible to participate in this study, you will be randomly assigned to one of these groups for 12 months. You will be asked to complete both online and telephone assessments at quarterly intervals across the 12 month study period.

There is a 1/3 chance that participants will be randomly assigned to a discussion board only group. While this is considered a control group, we do expect a modest benefit. All participants will have access to their allocated group for 12 months.

For more information, please visit:
www.moodswings.net.au

Deadline for Enrollment: Ongoing


Pharmacokinetics of Lamotrigine in Pregnant and Postpartum Women with Bipolar Disorder (Chicago, IL)

Background: Lamictal (lamotrigine) is FDA approved and commonly used to treat Bipolar Disorder. Because Bipolar Disorder frequently affects women during their reproductive years, it is important for us to understand how the dose of Lamictal should be modified for women who are pregnant. By participating in this study, you can help optimize the quality of care for women with Bipolar Disorder.

Goal: To understand the need for changes in dosage level of Lamictal for pregnant women with a history of Bipolar Disorder

Eligibility: Women ages 18-45; Diagnosis of Bipolar Disorder; Planning to become pregnant, or in the first or second trimester of pregnancy; Taking daily dose of Lamictal (lamotrigine) for mood symptom management What you will do: At your initial visit, you will complete a full psychiatric evaluation with Dr. Clark at no cost to you. At each subsequent visit, you will stay overnight in the clinical research unit and complete assessments to monitor your mood, as well as blood draws to monitor your lamotrigine levels.

Compensation: Reimbursement for on-site parking or public transportation; Financial compensation between $75-125 for every study visit you complete; Medical consultation with Dr. Crystal Clark about the best treatment for you throughout pregnancy; Gifts for you and your baby;  Careful monitoring of your mood symptoms throughout pregnancy at no cost to you Principal Investigator: Crystal T. Clark, MD, MSc

Contact
Stephanie Schuette
Phone: 312-695-6010
Email: nwu-sas375@northwestern.edu

Deadline for Enrollment: 09/30/2015


A Clinical Trial of Mobile Telephone based Assessment and Intervention for Persons with Bipolar Disorder or Schizophrenia (La Jolla (San Diego), CA)

The purpose of this study is to evaluate the effectiveness of a mobile real-time cognitive behavioral intervention for serious mental illness (SMI) and to identify the facilitators, barriers, and costs of implementation. We would like to determine whether the addition of a mobile phone monitoring software program to a brief behavioral intervention for bipolar disorder or schizophrenia improves symptoms arising from the disorders. We aim to address symptoms, improve socialization, medication adherence, and relapse prevention.

Inclusion criteria:

  • Diagnosis of Bipolar Disorder or Schizophrenia
  • No CBT in the past 5 years
  • Currently on a stable dose of medication

Participants cannot receive any cognitive behavior therapy while in the study. There are three different groups. One is treatment as usual, one is active control, and one is treatment. There is an equal change of being randomized in each group.

Contact:
David Isley
Phone: 858-822-7531
Email: daisley@ucsd.edu

Deadline for Enrollment: 05/31/2017


NIH Research Studies: Bipolar Disorder & Severe Irritability Symptoms (Bethesda, Maryland)

How do the brain and the symptoms change as children grow up?
(Enrolling Nationwide, Eligible Participants Ages 6-17)


Researchers will describe over time the moods and behavior of children use specialized testing and brain imaging to learn about specific brain changes associated with bipolar disorder or severe irritability in children. Studies involve 1-5 outpatient visits, with follow up visits as the child grows up. All clinical evaluations, research procedures, and outpatient visits are free of cost. Children and parents are compensated for participation. Travel and lodging expenses are paid by NIMH.

Participants must have a bipolar diagnosis, or have symptoms of severe irritability. Irritability symptoms include: difficulty handling frustration (severe temper tantrums and rages) and "hyper" behavior (distractible, hyperactive, trouble sleeping).

Call for more information and eligibility criteria.

Contact:
NIMH Irritable Kids
Phone: 301-496-8381, TTY: 1-866-411-1010
Email: irritablekids@mail.nih.gov
http://patientinfo.nimh.nih.gov/BipolarD

Deadline for Enrollment: Ongoing


Bipolar I Study: Depressed Episode

The purpose of the study is to evaluate the effectiveness and safety of the study medication in individuals with depressive symptoms, diagnosed with Bipolar I Disorder. The study medication will be used in addition to ongoing treatment with certain mood stabilizers and/or atypical antipsychotics. Participants need to be between 18 to 75 years of age, in generally good physical health and currently taking medication for bipolar disorder. Participation in the study will be from 8 to 12 weeks overall. Participants will receive study medication for a maximum of 6 weeks. Participants will receive compensation for their time and travel. All study related procedures and medications are provided at no cost.

Antidepressants and typical antipsychotics are prohibited during the study. Participants may not initiate cognitive or behavioral therapy, or psychotherapy during the study. Some participants will be randomly assigned to the placebo group. There is a one in three chance of being assigned to the placebo group during the dosing period (6weeks).

Contact:

City Contact Name E-Mail/Phone
Birmingham, AL Kay McLean pweldon@amhsinc.net
205-978-7840
Glendale, CA Annie Tran brstrials@gmail.com 
888-255-5798
Los Angeles, CA Christina Fosteson info@pacificmedresearch.com
310-208-7144
Oceanside, CA Tristin Smith tsmith@nccresearch.com
760-639-4378
Pico Rivera, CA Sharon Zabate sharon.zabate@cnrilallc.com
562-928-8601
Hartford, CT Sherri Post Sherri.Post@hhchealth.org
860-545-7502
Coral Springs, FL Jeannette Haglund cnsrsch@gmail.com
954-796-8222
Jacksonville, FL Khee Hayward shayward@cnshealthcare.com
904-281-5757
Maitland, FL Traci Howard info@flcrc.com
407-644-1165
Orlando, FL Natasha Mata nmata@cnshealthcare.com
407-425-5100
West Palm Beach, FL Bob Chaney bchaney@januspsychresearch.com
561-238-3030
Oak Brook, IL Farrah Khan fkhan@americanmedicalresearch.com
630-928-1000
Lafayette, IN Melinda Gick mgickalpine@aol.com
765-448-6445
Staten Island, NY Adam Smith smith@rbany.com
718-317-5522 ext 3
New York, NY Ioana Petruta research@mbhrpc.com
212-362-6657
Queens, NY Steve Stork sstork@cnsmail.com
800-993-8502
Avon Lake, OH Jennifer R reiterj12@gmail.com
440-930-2002
Garfield Heights, OH Martin Manuel
mmanuel@charakresearch.com
216-280-6374
Oklahoma City, OK Adele White awhite@redriverokc.com
405-759-4121
Memphis, TN Jason Bain jbain@cnshealthcare.com
901-843-1045
San Antonio, TX The Behavioral Wellness Center rodriguezj13@uthscsa.edu
210-562-5400
Waukesha, WI Shelley Schultz slschultz@ipcresearch.org
262-513-0700 

Deadline for Enrollment: December 2014


Stability - Bipolar I Depression Study (Skokie, IL & Chicago, IL)

Are you currently being treated for Bipolar Disorder and doing well?

We are looking for participants, with Bipolar Disorder who are stable to participate in our clinical research study. You must be currently taking medication for Bipolar I disorder to participate. Most medication combinations are acceptable.

Participants will be randomly assigned to 1 of 3 treatment groups or a placebo group - to receive remelteon (study medication) throughout the trial.

The purpose of the study is to if the study medication will keep participants stable, for longer periods.

*14 office visits over 9 months ($25 per visit paid)
*Ages 18-75
*Remission of BP symptoms past 8 weeks.
*25% chance of receiving placebo

Please call us today to further discuss the study design and inclusion criteria.

Contact:
Dr. Rae K. Watkins
Phone: 847-679-8000
Email: rae_watkins@rush.edu

Deadline for Enrollment: 01/05/2015


Bipolar I Depression (Skokie, IL & Chicago, IL.)

Are you taking medication for BP I disorder and still currently depressed?

We are looking for participants who are currently being treated with lithium, a mood stabilizer, or an atypical anti-psychotic but still experiencing symptoms of depressions.

Participants will be allowed to remain on their current medication and will be randomly assigned to 1 of 3 treatment groups or a placebo group. The study will assess the efficacy of ramelteon (currently approved to treat insomnia) as an add-on therapy in the treatment if Bipolar I Disorder.

Ages 18-75

Currently Depressed

9 office visits over 9 weeks ($25 per visit paid)

All study related procedures, including physical examinations proved at no cost. 25% chance that subjects will receive a placebo as their add on medication.

Contact:
Dr. Rae K. Watkins
Phone: 847-679-8000
Email: rae_watkins@rush.edu

Deadline for Enrollment: 01/05/2015


Bipolar Relapse Prevention - NIMH Study (Rush University Research Study conducted in Skokie, IL & Chicago, IL.)

The Bipolar relapse prevention study is a 17 visit, 62-week trial where subjects 18-65 who are currently depressed will be treated with the mood stabalizer lithium plus the antidepressant fluoxetine. This study begins with 12 weeks of treatment with fluoxetine plus lithium for mood symptoms. Subjects who respond (remission of symptoms) to the treatment will continue to receive lithium but will be randomly selected to continue receiving fluoxetine or switched to placebo. All Participants will recieve active medication through their participation in the study.

During the first 12-weeks of the study all subjects will be treated with fluoxetine and lithium. Subjects that are stable at the end of 12-weeks, will continue to receive lithium but will be radomized to receive fluoxetine or placebo (50/50 chance).

Contact:
Dr. Rae K. Watkins
Phone: 847-679-8000
Email: rae_watkins@rush.edu

Deadline for Enrollment: 01/01/2015


Bipolar Depression and Biological Rhythms (Chicago, Illinois)

Have you ever felt that your timing was off or that you were simply out of synch when depressed? Then you might want to participate in this study!

We are conducting a Northwestern University-funded study of biological rhythms in bipolar depression. By examining certain hormone (melatonin) and rest-activity rhythms, this study will clarify whether there is a timing disturbance in these rhythms during depression and suggest novel antidepressant strategies. This is not a clinical study: you will be able to continue your current treatment without change.

You may qualify if:

  • You have a diagnosis of bipolar disorder.
  • You are currently depressed.
  • You are between the ages of 18 and 55 years old.

This study involves the following procedures:

  • A clinical interview
  • Depression / Sleep questionnaires
  • Home-based saliva collection (2 nights)
  • Sleep/activity cycle monitoring via wristwatch sensor (2 weeks).
  • Participants are compensated approximately $400 over the course of the study which will last about 6-9 months.

Contact:

Eren Roubal
Phone: 312-503-1539
Email: e-roubal@northwestern.edu

Deadline for Enrollment: September 2014


Developing Brain Function in Adolescent (Chicago, IL)

Developing Brain Function in Adolescent Bipolar Disorder

This study focuses on the developmental changes in cognitive and affective neural circuitry functioning in adolescents with Pediatric Bipolar Disorder (PBD) over a three-year period. We will characterize the course of illness and associated neurocognitive function in patients with PBD as well as determine the association between brain function and behavior.

During the study, participants will complete a baseline diagnostic interview, clinical assessments, neurocognitive and neuropsychological tests, and a functional MRI brain scan. Participants will also have the option to draw blood for pharmacogenetic analyses. Testing will be repeated once a year for three years after the baseline visit, four visits total.

Contact:
Allison Lowes
(312) 355-1168
alowes@psych.uic.edu

Deadline for Enrollment: Ongoing


Bipolar Disorder Studies (Cincinnati, OH)

We are seeking participants who have experienced mood swings, periods of elation, excessive excitement, irritability, high energy, racing thoughts, poor sleep, poor judgment, and/or periods of depression. We have a large range of studies for adults, adolescents and children.

In addition, we are looking for children who are depressed or children who have a parent with bipolar disorder. We also have studies for adolescents with bipolar disorder who use substances.

Please visit our website to see a full listing of what we offer or contact Michelle or Jennifer below to see if you may be eligible for a study. http://www.psychiatry.uc.edu/ click on the clinical trials link on the left or participate in research at the bottom of the page.

Contact:
Michelle Durling - Adults
513-558-3674
michelle.durling@uc.edu

Jennifer Vaden - Children
513-558-4812
Jennifer.vaden@uc.edu

Deadline for Enrollment: January 1, 2015